IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 81 a 100 di 134
Data di pubblicazione Titolo Autore(i) Tipo File
1-gen-2018 Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid Caobelli, F; Chiaravalloti, A; Evangelista, L; Saladini, G; Schillaci, O; Vadrucci, M; Scalorbi, F; Donner, D; Alongi, P Articolo su rivista
1-gen-2018 Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study Chiaravalloti, A; Barbagallo, G; Ricci, M; Martorana, A; Ursini, F; Sannino, P; Karalis, G; Schillaci, O Articolo su rivista
1-mar-2018 Dopaminergic involvement in a drummer with focal dystonia: A case study Schirinzi, T; Scalise, S; Di Lazzaro, G; Cerroni, R; Chiaravalloti, A; Lavorenti Figueras, P; Pierantozzi, M; Pisani, A; Stefani, A Articolo su rivista
4-giu-2018 Metformin and autoimmunity: A "new deal" of an old drug Ursini, F; Russo, E; Pellino, G; D'Angelo, S; Chiaravalloti, A; De Sarro, G; Manfredini, R; De Giorgio, R Articolo su rivista
1-lug-2018 Correction to: Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid (Annals of Nuclear Medicine, (2018), 32, 1, (7-15), 10.1007/s12149-017-1213-0) Caobelli, F; Chiaravalloti, A; Evangelista, L; Saladini, G; Schillaci, O; Vadrucci, M; Scalorbi, F; Donner, D; Alongi, P Articolo su rivista
1-ago-2018 Coupled Imaging with [ 18 F]FBB and [ 18 F]FDG in AD Subjects Show a Selective Association Between Amyloid Burden and Cortical Dysfunction in the Brain Chiaravalloti, A; Castellano, Ae; Ricci, M; Barbagallo, G; Sannino, P; Ursini, F; Karalis, G; Schillaci, O Articolo su rivista
1-ago-2018 18F-labeled radiopharmaceuticals for the molecular neuroimaging of amyloid plaques in Alzheimer's disease Filippi, L; Chiaravalloti, A; Bagni, O; Schillaci, O Articolo su rivista
1-gen-2019 Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study Liguori, C; Ruffini, R; Olivola, E; Chiaravalloti, A; Izzi, F; Stefani, A; Pierantozzi, M; Mercuri, Nb; Modugno, N; Centonze, D; Schillaci, O; Placidi, F Articolo su rivista
1-gen-2019 A rare case of primary uterine non-hodgkins's lymphoma with involvement of right ovary: Staging with 18F FDG PET/CT and iodinated contrast CT Lamacchia, F; Cimini, A; Ferrari, D; Chiaravalloti, A; Schillaci, O; Floris, R Articolo su rivista
1-gen-2019 Hearing and cognitive impairment: a functional evaluation of associative brain areas in patients affected by Alzheimer's disease Chiaravalloti, A; Fuccillo, E; Martorana, A; Ricci, M; Giacomini, Pg; Schillaci, O; Di Girolamo, S Articolo su rivista
1-gen-2019 Evaluation of Task-Related Brain Activity: Is There a Role for 18F FDG-PET Imaging? Chiaravalloti, A; Micarelli, A; Ricci, M; Pagani, M; Ciccariello, G; Bruno, E; Alessandrini, M; Schillaci, O Articolo su rivista
1-gen-2019 The role of 18f-fdg pet/ct in staging and prognostication of mantle cell lymphoma: An italian multicentric study Albano, D; Laudicella, R; Ferro, P; Allocca, M; Abenavoli, E; Buschiazzo, A; Castellino, A; Chiaravalloti, A; Cuccaro, A; Cuppari, L; Durmo, R; Evangelista, L; Frantellizzi, V; Kovalchuk, S; Linguanti, F; Santo, G; Bauckneht, M; Annunziata, S Articolo su rivista
1-gen-2019 The role of molecular imaging in the frame of the revised dementia with Lewy body criteria Sestini, S; Alongi, P; Berti, V; Calcagni, Ml; Cecchin, D; Chiaravalloti, A; Chincarini, A; Cistaro, A; Guerra, Up; Pappatà, S; Tiraboschi, P; Nobili, F Articolo su rivista
1-gen-2019 Molecular imaging in pediatric brain tumors Chiaravalloti, A; Filippi, L; Ricci, M; Cimini, A; Schillaci, O Articolo su rivista
1-gen-2019 Evaluation of the usefulness of FDG-PET/CT for nodal staging of breast cancer Orsaria, P; Chiaravalloti, A; Caredda, E; Marchese, Pv; Titka, B; Anemona, L; Portarena, I; Schillaci, O; Petrella, G; Palombi, L; Buonomo, Oc Articolo su rivista
1-gen-2019 Prostate cancer and inflammation: A new molecular imaging challenge in the era of personalized medicine Schillaci, O; Scimeca, M; Trivigno, D; Chiaravalloti, A; Facchetti, S; Anemona, L; Bonfiglio, R; Santeusanio, G; Tancredi, V; Bonanno, E; Urbano, N; Mauriello, A Articolo su rivista
1-gen-2019 A patient with a benign and a malignant primary pulmonary meningioma: An evaluation with 18F fluorodeoxyglucose positron emission tomography/computed tomography and computed tomography with iodinated contrast Cimini, A; Ricci, F; Pugliese, L; Chiaravalloti, A; Schillaci, O; Floris, R Articolo su rivista
23-mar-2019 Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study Liguori, C; Ruffini, R; Olivola, E; Chiaravalloti, A; Izzi, F; Stefani, A; Pierantozzi, M; Mercuri, Nb; Modugno, N; Centonze, D; Schillaci, O; Placidi, F Articolo su rivista
4-apr-2019 Overall survival and progression-free survival in patients with primary brain tumors after treatment: is the outcome of [18F] FDOPA PET a prognostic factor in these patients? Chiaravalloti, A; Esposito, V; Ursini, F; Di Giorgio, E; Zinzi, M; Calabria, F; Cimini, A; Schillaci, O Articolo su rivista
1-giu-2019 Brain metabolic patterns in patients with suspected non-Alzheimer’s pathophysiology (SNAP) and Alzheimer’s disease (AD): is [18F] FDG a specific biomarker in these patients? Chiaravalloti, A; Barbagallo, G; Martorana, A; Castellano, Ae; Ursini, F; Schillaci, O Articolo su rivista
Mostrati risultati da 81 a 100 di 134
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile